Imaging genomics applied to anxiety, stress response, and resiliency

Neuroinformatics

Volumn 4, Issue 1, 2006, Pages 51-64

  Xu, Ke ^a   Ernst, Monique ^b   Goldman, David ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

5 HTT; Anxiety; COMT; Imaging genomics

Indexed keywords

CARBON 11; CARFENTANIL; CATECHOL METHYLTRANSFERASE; FLUOXETINE; OPIATE; SEROTONIN TRANSPORTER;

ALLELE; AMYGDALOID NUCLEUS; ANXIETY; ANXIETY DISORDER; BRAIN FUNCTION; COGNITION; DEPRESSION; DYSPHORIA; EMOTIONALITY; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HUMAN; NEUROIMAGING; NONHUMAN; PAIN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REVIEW; SENSITIVITY ANALYSIS; STIMULUS RESPONSE; STRESS; UPREGULATION; ADAPTIVE BEHAVIOR; BRAIN LEVEL; BRAIN MAPPING; DIAGNOSTIC IMAGING; GENETIC PREDISPOSITION; GENETICS; MENTAL STRESS; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADAPTATION, PSYCHOLOGICAL; ANXIETY DISORDERS; BRAIN CHEMISTRY; BRAIN MAPPING; CATECHOL O-METHYLTRANSFERASE; DIAGNOSTIC IMAGING; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STRESS, PSYCHOLOGICAL;

EID: 33646690034     PISSN: 15392791     EISSN: None     Source Type: Journal    
DOI: 10.1385/NI:4:1:51     Document Type: Review

References (107)

1. Amaral, D. G. and Price, J. L. (1984) Amygdala-cortical projections in the monkey (Macaca fascicularis). J. Comp. Neurol. 230, 465-496.
2. Ansorge, M. S., Zhou, M., Lira, A., Hen, R., and Gingrich, J. A. (2004) Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306, 879-881.
3. Baldwin, D. S. (2002) Escitalopram: efficacy and tolerability in the treatment of depression. Hosp. Med. 63, 668-671.
4. Barr, C. S., Newman, T. K., Lindell, S., et al. (2004) Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates. Arch. Gen. Psychiatry 61, 1146-1152.
5. Bearden, C. E., Jawad, A. F., Lynch, D. R., et al. (2004) Effects of a functional COMT polymorphism on prefrontal cognitive function in patients with 22q11.2 deletion syndrome. Am. J. Psychiatry 161, 1700-1702.
6. Bilder, R. M., Volavka, J., Czobor, P., et al. (2002) Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol. Psychiatry 52, 701-707.
7. Bray, N. J., Buckland, P. R., Williams, N. M., et al. (2003) A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am. J. Hum. Genet. 73, 152-161.
8. Brody, A. L., Saxena, S., Mandelkern, M. A., Fairbanks, L. A., Ho, M. L., and Baxter, L. R. (2001) Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol. Psychiatry 50, 171-178.
9. Camp, N. J., Lowry, M. R., Richards, R. L., et al. (2005) Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. Am. J. Med. Genet. B Neuropsychiatry Genet. 135, 85-93.
10. Caspi, A., McClay, J., Moffitt, T. E., et al. (2002) Role of genotype in the cycle of violence in maltreated children. Science 297, 851-854.
11. Caspi, A., Sugden, K., Moffitt, T. E., et al. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389.
12. Chen, J., Lipska, B. K., Halim, N., et al. (2004) Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 75, 807-821.
13. Cloninger, C. R., Van Eerdewegh, P., Goate, A., et al. (1998) Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am. J. Med. Genet. 81, 313-317.
14. Davis, M. and Whalen, P. J. (2001) The amygdala: vigilance and emotion. Mol. Psychiatry 6, 13-34.
15. Diatchenko, L., Slade, G. D., Nackley, A. G., et al. (2005) Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum. Mol. Genet. 14, 135-143.
16. Dina, C., Nemanov, L., Gritsenko, I., et al. (2005) Fine mapping of a region on chromosome 8p gives evidence for a QTL contributing to individual differences in an anxiety-related personality trait: TPQ harm avoidance. Am. J. Med. Genet. B Neuropsychiatry Genet. 132, 104-108.
17. Drevets, W. C. (2000) Neuroimaging studies of mood disorders. Biol. Psychiatry 48, 813-829.
18. Ebstein, R. P., Novick, O., Umansky, R., et al. (1996) Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat. Genet. 12, 78-80.
19. Egan, M. F., Goldberg, T. E., Kolachana, B. S., et al. (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. USA 98, 6917-6922.
20. Eley, T. C. (1999) Behavioral genetics as a tool for developmental psychology: anxiety and depression in children and adolescents. Clin. Child Fam. Psychol. Rev. 2, 21-36.
21. Eley, T. C., Bolton, D., O'Connor, T. G., Perrin, S., Smith, P., and Plomin R. (2003) A twin study of anxiety-related behaviours in pre-school children. J. Child Psychol. Psychiatry 44, 945-960.
22. Enoch, M. A., Schuckit, M. A., Johnson, B. A., and Goldman D (2003a) Genetics of alcoholism using intermediate phenotypes. Alcohol Clin. Exp. Res. 27, 169-176.
23. Enoch, M. A., Xu, K., Ferro, E., Harris, C. R., and Goldman D. (2003b) Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatry Genet. 13, 33-41.
24. Furmark, T., Tillfors, M., Garpenstrand, H., et al. (2004) Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci. Lett. 362, 189-192.
25. Gelernter, J., Page, G. P., Stein, M. B., and Woods, S. W. (2004) Genome-wide linkage scan for loci predisposing to social phobia: evidence for a chromosome 16 risk locus. Am. J. Psychiatry 161, 59-66.
26. Gogos, J. A., Morgan, M., Luine, V., et al. (1998) Catechol-O- methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. USA 95, 9991-9996.
27. Goldberg, T. E., Egan, M. F., Gscheidle, T., et al. (2003) Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch. Gen. Psychiatry 60, 889-896.
28. Goldman-Rakic, P. S., Lidow, M. S., Smiley, J. F., and Williams, M. S. (1992) The anatomy of dopamine in monkey and human pref rental cortex. J. Neural Transm. Suppl. 36, 163-177.
29. Gorman, J. M., Kent, J. M., Sullivan, G. M., and Coplan, J. D. (2000) Neuroanatomical hypothesis of panic disorder, revised. Am. J. Psychiatry 157, 493-505.
30. Graeff, F. G. (2002) On serotonin and experimental anxiety. Psychopharmacology (Berl.) 163, 467-476.
31. Granon, S., Passetti, F., Thomas, K. L., Dalley, J. W., Everitt, B. J., and Robbins, T. W. (2000) Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J. Neurosci. 20, 1208-1215.
32. Hamilton, S. P., Slager, S. L., De Leon, A. B., et al. (2004) Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 29, 558-565.
33. Hamilton, S. P., Slager, S. L., Heiman, G. A., et al. (2002) Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol. Psychiatry 51, 591-601.
34. Hariri, A. R., Bookheimer, S. Y., and Mazziotta, J. C. (2000) Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport 11, 43-48.
35. Hariri, A. R., Drabant, E. M., Munoz, K. E., et al. (2005) A susceptibility gene for affective disorders and the response of the human amygdala. Arch. Gen. Psychiatry 62, 146-152.
36. Hariri, A. R., Mattay, V. S., Tessitore, A., et al. (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297, 400-403.
37. Hariri, A. R. and Weinberger, D. R. (2003a) Functional neuroimaging of genetic variation in serotonergic neurotransmission. Genes Brain Behav. 2, 341-349.
38. Hariri, A. R. and Weinberger, D. R. (2003b) Imaging genomics. Br. Med. Bull. 65, 259-270.
39. Heils, A., Teufel, A., Petri, S., et al. (1995) Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J. Neural Transm. Gen. Sect. 102, 247-254.
40. Heils, A., Teufel, A., Petri, S., et al. (1996) Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66, 2621-2624.
41. Heinz, A., Braus, D. F., Smolka, M. N., et al. (2005) Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat. Neurosci. 8, 20, 21.
42. Heinz, A., Jones, D. W., Mazzanti, C., et al. (2000) A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol. Psychiatry 47, 643-649.
43. Hettema, J. M., Prescott, C. A., and Kendler, K. S. (2003) The effects of anxiety, substance use and conduct disorders on risk of major depressive disorder. Psychol. Med. 33, 1423-1432.
44. Hettema, J. M., Prescott, C. A., and Kendler, K. S. (2004) Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism. Am. J. Psychiatry 161, 1581-1587.
45. Hidalgo, R. B. and Davidson, J. R. (2000) Selective serotonin reuptake inhibitors in post-traumatic stress disorder. J. Psychopharmacol. 14, 70-76.
46. Holmes, A., Yang, R. J., Lesch, K. P., Crawley, J. N., and Murphy, D. L. (2003) Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 28, 2077-2088.
47. Hu, X., Lipsky, R. H., Zhu, G., and Goldman, D. (2004) HTTLPR allele expresion is condominant, correlating with gene effects on fMRI and SPET imaging intermediate phenotypes, and behavior. Biol. Psychiatry 55, 1915.
48. Hu, X., Oroszi, G., Chun, J., Smith, T. L., Goldman, D., and Schuckit, M. A. (2005) An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin. Exp. Res. 29, 8-16.
49. Ichimiya, T., Suhara, T., Sudo, Y., et al. (2002) Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+) McN5652. Biol. Psychiatry 51, 715-722.
50. Iwata, N., Cowley, D. S., Radel, M., Roy-Byrne, P. P., and Goldman D. (1999) Relationship between a GABAA alpha 6 Pro385Ser substitution and benzodiazepine sensitivity. Am. J. Psychiatry 156, 1447-1449.
51. Jiang, X., Xu, K., Hoberman, J., et al. (2005) BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30, 1353-1361.
52. Joober, R., Gauthier, J., Lal, S., et al. (2002) Catechol-O-methyltransf erase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch. Gen. Psychiatry 59, 662, 663.
53. Katsuragi, S., Kunugi, H., Sano, A., et al. (1999) Association between serotonin transporter gene polymorphism and anxiety-related traits. Biol. Psychiatry 45, 368-370.
54. Keightley, M. L., Seminowicz, D. A., Bagby, R. M., Costa, P. T., Fossati, P., Mayberg, H. S. (2003) Personality influences limbic-cortical interactions during sad mood induction. Neuroimage 20, 2031-2039.
55. Koss, M. P., Yuan, N. P., Dightman, D., et al. (2003) Adverse childhood exposures and alcohol dependence among seven Native American tribes. Am. J. Prev. Med. 25, 238-244.
56. Lam, P., Hong, C. J., and Tsai, S. J. (2005) Association study of A2a adenosine receptor genetic polymorphism in panic disorder. Neurosci. Lett. 378, 98-101.
57. Ledoux, J. E. and Muller J. (1997) Emotional memory and psychopathology. Philos. Trans. R. Soc. Lond. B Biol. Sci. 352, 1719-1726.
58. Lesch, K. P., Balling, U., Gross, J., et al. (1994) Organization of the human serotonin transporter gene. J. Neural Transm. Gen. Sect. 95, 157-162.
59. Lesch, K. P., Bengel, D., Heils, A., et al. (1996a) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
60. Lesch, K. P., Heils, A., and Riederer, P. (1996b) The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes. J. Mol. Med. 74, 365-378.
61. Lesch, K. P. and Mossner R. (1998) Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol. Psychiatry 44, 179-192.
62. Levesque, J., Jeanette, Y., Mensour, B., et al. (2003) Neural correlates of sad feelings in healthy girls. Neuroscience 121, 545-551.
63. Lewis, D. A., Melchitzky, D. S., Sesack, S. R., Whitehead, R. E., Auh, S., and Sampson, A. (2001) Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J. Comp. Neurol. 432, 119-136.
64. Lipsky, R. H., Sparling, M. B., Ryan, L. M., et al. (2005) Association of COMT Val158Met polymorphism with executive functioning following traumatic brain injury. J. Neuropsych. Clin. N., in press.
65. Little, K. Y., McLauglin, D. P., Ranc, J., et al. (1997) Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide. Biol. Psychiatry 41, 1156-1164.
66. MacDonald, A. W., IIIrd and Carter, C. S. (2003) Event-related FMRI study of context processing in dorsolateral prefrontal cortex of patients with schizophrenia. J. Abnorm. Psychol. 112, 689-697.
67. Malhotra, A. K., Kestler, L. J., Mazzanti, C., Bates, J. A., Goldberg, T., and Goldman, D. (2002) A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry 159, 652-654.
68. Markowitsch, H. J., Vandekerckhovel, M. M., Lanfermann, H., and Russ, M. O. (2003) Engagement of lateral and medial prefrontal areas in the ecphory of sad and happy autobiographical memories. Cortex 39, 643-665.
69. Mattay, V. S., Frank, J. A., Santha, A. K., et al. (1996) Whole-brain functional mapping with isotropic MR imaging. Radiology 201, 399-404.
70. Mazei, M. S., Pluto, C. P., Kirkbride, B., and Pehek, E. A. (2002) Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat. Brain Res. 936, 58-67.
71. Mazzanti, C. M., Lappalainen, J., Long, J. C., et al. (1998) Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch. Gen. Psychiatry 55, 936-940.
72. Mehta, M. A., Owen, A. M., Sahakian, B. J., Mavaddat, N., Pickard, J. D., and Robbins, T. W. (2000) Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J. Neurosci. 20, RC65.
73. Meyer, J. H., Houle, S., Sagrati, S., et al. (2004) Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch. Gen. Psychiatry 61, 1271-1279.
74. Meyer-Lindenberg, A., Kohn, P. D., Kolachana, B., et al. (2005) Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat. Neurosci. 8, 594-596.
75. Millet, B., Chabane, N., Delorme, R., et al. (2003) Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am. J. Med. Genet. B Neuropsychiatry Genet. 116, 55-59.
76. Murphy, D. L., Li, Q., Engel, S., et al. (2001) Genetic perspectives on the serotonin transporter. Brain Res. Bull. 56, 487-494.
77. Nakamura, M., Ueno, S., Sano, A., and Tanabe H. (2000) The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol. Psychiatry 5, 32-38.
78. Nolan, K. A., Bilder, R. M., Lachman, H. M., and Volavka J. (2004) Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met al.leles on cognitive stability and flexibility. Am. J. Psychiatry 161, 359-361.
79. Papolos, D. F., Faedda, G. L., Veit, S., et al. (1996) Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am. J. Psychiatry 153, 1541-1547.
80. Pelletier, M., Bouthillier, A., Levesque, J., et al. (2003) Separate neural circuits for primary emotions? Brain activity during self-induced sadness and happiness in professional actors. Neuroreport 14, 1111-1116.
81. Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., et al. (2005) 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 8, 828-834.
82. Pine, D. S., Mogg, K., Bradley, B. P., et al. (2005) Attention bias to threat in maltreated children: implications for vulnerability to stress-related psychopathology. Am. J. Psychiatry 162, 291-296.
83. Pollock, B. G. (2001) Citalopram: a comprehensive review. Expert Opin. Pharmacother. 2, 681-698.
84. Ramamoorthy, S., Bauman, A. L., Moore, K. R., et al. (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. USA 90, 2542-2546.
85. Rauch, S. L., Shin, L. M., and Wright, C. I. (2003) Neuroimaging studies of amygdala function in anxiety disorders. Ann. NY Acad. Sci. 985, 389-410.
86. Rickels, K., Zaninelli, R., McCafferty, J., Bellew, K., Iyengar, M., and Sheehan, D. (2003) Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study. Am. J. Psychiatry 160, 749-756.
87. Robin, R. W., Chester, B., Rasmussen, J. K., Jaranson, J. M., and Goldman, D. (1997) Prevalence and characteristics of trauma and posttraumatic stress disorder in a southwestern American Indian community. Am. J. Psychiatry 154, 1582-1588.
88. Rosa, A., Peralta, V., Cuesta, M. J., et al. (2004) New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am. J. Psychiatry 161, 1110-1112.
89. Savitz, J. B. and Ramesar, R. S. (2004) Genetic variants implicated in personality: a review of the more promising candidates. Am. J. Med. Genet. B Neuropsychiatr. Genet. 131, 20-32.
90. Sawaguchi, T. and Goldman-Rakic, P. S. (1991) D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251, 947-950.
91. Scanlon, P. D., Raymond, F. A., and Weinshilboum, R. M. (1979) Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. Science 203, 63-65.
92. Seamans, J. K., Floresco, S. B., and Phillips, A. G. (1998) D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. J. Neurosci. 18, 1613-1621.
93. Sen, S., Burmeister, M., and Ghosh, D. (2004) Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am. J. Med. Genet. B Neuropsychiatr. Genet. 127, 85-89.
94. Serretti, A., Cusin, C., Rossini, D., Artioli, P., Dotoli, D., and Zanardi, R. (2004) Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 129, 36-40.
95. Shifman, S., Bronstein, M., Sternfeld, M., et al. (2002) A highly significant association between a COMT haplotype and schizophrenia. Am. J. Hum. Genet. 71, 1296-1302.
96. Shioe, K., Ichimiya, T., Suhara, T., et al. (2003) No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 48, 184-188.
97. Smolka, M. N., Schumann, G., Wrase, J., et al. (2005) Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J. Neurosci. 25, 836-842.
98. Stevenson, J., Batten, N., and Cherner, M. (1992) Fears and fearfulness in children and adolescents: a genetic analysis of twin data. J. Child Psychol. Psychiatry 33, 977-985.
99. Thapar, A. and McGuffin, P. (1995) Are anxiety symptoms in childhood heritable? J. Child Psychol. Psychiatry 36, 439-447.
100. Tjurmina, O. A., Armando, I., Saavedra, J. M., Goldstein, D. S., and Murphy, D. L. (2002) Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology 143, 4520-4526.
101. Weinshilboum, R. and Dunnette, J. (1981) Thermal stability and the biochemical genetics of erythrocyte catechol-O-methyl-transferase and plasma dopamine-beta-hydroxylase. Clin. Genet. 19, 426-437.
102. Weinshilboum, R. M., Otterness, D. M., and Szumlanski, C. L. (1999) Methylation pharmacogenetics: catechol-O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu. Rev. Pharmacol. Toxicol. 39, 19-52.
103. Williamson, D. E., Coleman, K., Bacanu, S. A., et al. (2003) Heritability of fearful-anxious endophenotypes in infant rhesus macaques: a preliminary report. Biol. Psychiatry 53, 284-291.
104. Xu, K. and Goldman, D. (2005) Catechol-O-methyltransferase genotype. Intermediate phenotype and psychiatric disorders, in Cell Biology of Addiction. Cold Spring Harbor Laboratory Press, cold Spring Harbor, NY: in press.
105. Zhu, G., Lipsky R. H., Xu, K., et al. (2004) Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5′ nuclease assay. Psychopharmacology (Berl.) 177, 178-184.
106. Zubieta, J. K., Heitzeg, M. M., Smith, Y. R., et al. (2003) COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299, 1240-1243.
107. Zubieta, J. K., Smith, Y. R., Bueller, J. A., et al. (2002) mu-opioid receptor-mediated antinociceptive responses differ in men and women. J. Neurosci. 22, 5100-5107.